WHY DIVERSE HYDRO
While Diverse Biotech continues to advance techniques in the field of oncology, the pharmaceutical landscape is continuing to improve supply chain logistics and the overall quality of raw ingredients used in manufacturing. Our answer to these challenges, is a comprehensive “Clone to Bottle” process of ownership we call Diverse Hydro.
Diverse Hydro is focused on maximizing our biomass plant yields while incorporating renewable energy technologies into responsible manufacturing. Hydroponics, Hydroelectric, and Solar are active methods we incorporate into our greenhouse facilities.
As the industrial hemp market continues to mature, we provide legal, state approved, and compliant cannabinoids to our research efforts. Insuring consistent and superior quality of cannabinoids to our over the counter (OTC) and clinical formulations.
Diverse Hydro is a rapidly growing division within Diverse Biotech, providing real solutions to supply chain challenges in the growth and cultivation of cannabinoids. We continue to increase our organizations share value through revenue and reliability. Working in tandem with Diverse Pharma, our standards are at minimum GMP and pharmaceutical grade regulations.
Modern cultivation often occurs in a soilless environment. Hydroponics allow Diverse Hydro to cultivate year round (4 crops per year) in a closed environment, producing maximum plant yields per square foot which commercial farming is not able to attain.
Our cultivation of unique cannabinoid clones ensure exact formulas, maximum plant growth, and the highest levels of production possible. Each facility includes sophisticated irrigation systems, multi stage lighting, advanced air filtration, atmospheric controls for temperature regulation, and proprietary nutrient cycles.
We provide cutting edge drying, processing, and cannabinoid extraction processes designed to meet the needs of Diverse Pharma requirements. These computerized automation systems control lighting, irrigation and temperature to ensure the proper growing environment.
The cannabis plant (Cannabis sativa L.) contains a large number of pharmacologically active compounds called phytocannabinoids. The most abundant of these compounds are ∆9-tetrahydrocannabinol (THC) and CBD, although the amounts and proportions of the various phytocannabinoids in each plant vary by strain and can be adjusted by breeding.
Cannabinoids have been shown to cause antitumor effects by various mechanisms, including:
Diverse Biotech’s proprietary cannabinoid formulations are derived from extracts of Cannabis sativa L. plants, i.e., hemp, that have a defined chemical profile and contain consistent levels of phytocannabinoids. Extracts from plants are processed separately to yield pure (>95%) cannabinoid isolates.